Stevanato Group S.p.A (STVN) Non-Current Deferred Tax Liability (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Non-Current Deferred Tax Liability of $17.1 million for Q1 2026, up 27.5% year-over-year from $13.4 million in Q1 2025, and up 11.0% quarter-over-quarter from $15.4 million in Q4 2025.
Stevanato Group S.p.A (STVN) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Non-Current Deferred Tax Liability for 7 consecutive years, with $17.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability rose 27.5% year-over-year to $17.1 million; the TTM figure through Mar 2026 stood at $17.1 million (up 27.5% YoY), while the FY2025 annual figure was $15.4 million, up 214.63% from the prior year.
- Non-Current Deferred Tax Liability advanced to $17.1 million in Q1 2026 per STVN's latest filing, from $15.4 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $23.1 million in Q2 2023 and bottomed at -$21.4 million in Q4 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $11.0 million across 5 years, with a median of $14.6 million in 2025.
- Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability jumped 233.43% — and 2023, when it slumped 53.27%.
- Stevanato Group S.p.A's Non-Current Deferred Tax Liability stood at -$21.4 million in 2022, then surged by 51.79% to -$10.3 million in 2023, then slumped by 30.35% to -$13.5 million in 2024, then soared by 214.63% to $15.4 million in 2025, then climbed by 11.0% to $17.1 million in 2026.
- Business Quant data shows STVN's Non-Current Deferred Tax Liability at $17.1 million in Q1 2026, $15.4 million in Q4 2025, and $15.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.18 Mn |
| Jun 30, 2026 | 16.18 Mn |
| Mar 31, 2026 | 17.13 Mn |
| Mar 31, 2026 | 17.13 Mn |
| Dec 31, 2025 | 15.43 Mn |
| Dec 31, 2025 | 15.43 Mn |
| Sep 30, 2025 | 15.49 Mn |
| Sep 30, 2025 | 15.49 Mn |
| Jun 30, 2025 | 14.63 Mn |
| Jun 30, 2025 | 14.63 Mn |
| Mar 31, 2025 | 13.44 Mn |
| Mar 31, 2025 | 13.44 Mn |
| Dec 31, 2024 | -13.46 Mn |
| Dec 31, 2024 | -13.46 Mn |
| Sep 30, 2024 | 11.88 Mn |
| Sep 30, 2024 | 11.88 Mn |
| Jun 30, 2024 | 11.38 Mn |
| Jun 30, 2024 | 11.38 Mn |
| Mar 31, 2024 | 11.10 Mn |
| Mar 31, 2024 | 11.10 Mn |